Clinical Predictors of Response to Treatment with Tofacitinib (Janus Kinase Inhibitor) in Patients with Ankylosing Spondylitis. Indus Journal of Bioscience Research, [S. l.], v. 3, n. 4, p. 175–181, 2025. DOI: 10.70749/ijbr.v3i4.1020. Disponível em: https://ijbr.com.pk/IJBR/article/view/1020. Acesso em: 14 aug. 2025.